Objective: This randomised comparative clinical trial aimed to assess the effectiveness and
tolerability of combining oxytocin and misoprostol for preventing immediate postpartum …

Postpartum hemorrhage (PPH) is the commonest cause of maternal death worldwide.
Studies suggest that the use of misoprostol may be beneficial in clinical settings where …

Background: In developing countries, postpartum hemorrhage is responsible for 30% of
maternal deaths. Although the World Health Organization recommends the use of oxytocin …

Post-partum hemorrhage (PPH) is a common cause of maternal mortality in developing
countries. Active management of postpartum hemorrhage by an uterotonic drug decreases …

Background: Postpartum hemorrhage (PPH) is considered the most common cause of
mortality in cesarean section (CS), and vaginal deliveries and to intercept the uterine …

Background: In low-resource regions of world, misoprostol, with or without oxytocin, has
recently emerged as an effective substitute for oxytocin for preventing postpartum …

Background There is some evidence that suggests misoprostol may supplement the action
of oxytocin in preventing post-partum haemorrhage (PPH). The primary objective of this …

Background: Postpartum hemorrhage is one of the most common obstetrical complications
affecting up to 18% of deliveries. Globally, it is responsible for 35–55% of peripartum …

Aim: The aim of this study was to evaluate the efficacy of adjunctive rectal misoprostol
compared to oxytocin infusion in the prevention of primary postpartum hemorrhage after …

Introduction: Postpartum hemorrhage (PPH) is a life-threatening obstetric emergency that
occurs after caesarean section (CS) or normal vaginal delivery (NVD). It may be defined …